Patent · US Active

Agents for the treatment of celiac disease

US8835603B2 · kind B2 · utility

7Cited by
22References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 30, 2009
Grant dateSep 16, 2014
Priority date
Expiry dateNov 30, 2029

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides agents and vaccines for treating and diagnosing celiac disease. In particular, the present invention provides a combination of three peptides that are useful for treating and diagnosing celiac disease in a large proportion of patients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.